KCTD19
gene geneOn this page
Also known as FLJ40162
Summary
KCTD19 (potassium channel tetramerization domain containing 19, HGNC:24753) is a protein-coding gene on chromosome 16q22.1, encoding BTB/POZ domain-containing protein KCTD19 (Q17RG1). Transcription regulator which is essential for male fertility and for the completion of meiotic prophase in spermatocytes.
Predicted to enable identical protein binding activity. Predicted to be involved in male meiotic nuclear division. Predicted to be located in nucleus.
Source: NCBI Gene 146212 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 135 total — 1 likely-pathogenic
- MANE Select transcript:
NM_001100915
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24753 |
| Approved symbol | KCTD19 |
| Name | potassium channel tetramerization domain containing 19 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40162 |
| Ensembl gene | ENSG00000168676 |
| Ensembl biotype | protein_coding |
| OMIM | 619943 |
| Entrez | 146212 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 4 protein_coding, 4 retained_intron, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000304372, ENST00000561625, ENST00000562721, ENST00000562841, ENST00000562860, ENST00000566295, ENST00000566392, ENST00000567976, ENST00000568736, ENST00000569333, ENST00000570049
RefSeq mRNA: 1 — MANE Select: NM_001100915
NM_001100915
CCDS: CCDS42179
Canonical transcript exons
ENST00000304372 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001480565 | 67289432 | 67289682 |
| ENSE00002583723 | 67326705 | 67326741 |
| ENSE00003465170 | 67304421 | 67304571 |
| ENSE00003486672 | 67320589 | 67320885 |
| ENSE00003520093 | 67290885 | 67290986 |
| ENSE00003535633 | 67297503 | 67297663 |
| ENSE00003540842 | 67291646 | 67291837 |
| ENSE00003543555 | 67296159 | 67296259 |
| ENSE00003550729 | 67295263 | 67295405 |
| ENSE00003581946 | 67293544 | 67294171 |
| ENSE00003613962 | 67303146 | 67303337 |
| ENSE00003646095 | 67294973 | 67295056 |
| ENSE00003648314 | 67299363 | 67299573 |
| ENSE00003662011 | 67294580 | 67294694 |
| ENSE00003665591 | 67291309 | 67291463 |
| ENSE00003686201 | 67301791 | 67301922 |
Expression profiles
Bgee: expression breadth ubiquitous, 147 present calls, max score 95.16.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3292 / max 120.4397, expressed in 124 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157763 | 0.2944 | 115 |
| 157765 | 0.0180 | 6 |
| 157762 | 0.0100 | 3 |
| 157764 | 0.0068 | 2 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 95.16 | gold quality |
| left testis | UBERON:0004533 | 95.01 | gold quality |
| testis | UBERON:0000473 | 91.46 | gold quality |
| adult organism | UBERON:0007023 | 84.15 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.27 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.40 | gold quality |
| upper arm skin | UBERON:0004263 | 75.70 | gold quality |
| kidney epithelium | UBERON:0004819 | 68.21 | gold quality |
| vastus lateralis | UBERON:0001379 | 67.00 | gold quality |
| quadriceps femoris | UBERON:0001377 | 66.58 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 66.56 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 66.28 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 65.64 | gold quality |
| ventricular zone | UBERON:0003053 | 64.97 | gold quality |
| biceps brachii | UBERON:0001507 | 64.30 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 63.74 | gold quality |
| sperm | CL:0000019 | 62.31 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 61.69 | gold quality |
| stromal cell of endometrium | CL:0002255 | 60.82 | gold quality |
| putamen | UBERON:0001874 | 60.68 | gold quality |
| decidua | UBERON:0002450 | 60.11 | gold quality |
| islet of Langerhans | UBERON:0000006 | 60.07 | gold quality |
| muscle tissue | UBERON:0002385 | 59.06 | gold quality |
| adrenal tissue | UBERON:0018303 | 59.05 | gold quality |
| deltoid | UBERON:0001476 | 58.84 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 58.29 | gold quality |
| caudate nucleus | UBERON:0001873 | 58.25 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 58.22 | gold quality |
| sural nerve | UBERON:0015488 | 58.08 | silver quality |
| substantia nigra pars compacta | UBERON:0001965 | 57.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.70 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Biallelic variants in KCTD19 associated with male factor infertility and oligoasthenoteratozoospermia. (PMID:37192818)
- Homozygous nonsense variants of KCTD19 cause male infertility in humans and mice. (PMID:37257643)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Kctd19 | ENSMUSG00000051648 |
| rattus_norvegicus | Kctd19 | ENSRNOG00000016760 |
| drosophila_melanogaster | twz | FBGN0034636 |
| caenorhabditis_elegans | F32B4.5 | WBGENE00009315 |
Paralogs (13): KCTD1 (ENSG00000134504), KCTD14 (ENSG00000151364), KCTD15 (ENSG00000153885), KCTD18 (ENSG00000155729), KCTD6 (ENSG00000168301), KCTD12 (ENSG00000178695), KCTD4 (ENSG00000180332), KCTD16 (ENSG00000183775), KCTD8 (ENSG00000183783), KCTD21 (ENSG00000188997), KCNRG (ENSG00000198553), KCTD11 (ENSG00000213859), KCTD7 (ENSG00000243335)
Protein
Protein identifiers
BTB/POZ domain-containing protein KCTD19 — Q17RG1 (reviewed: Q17RG1)
Alternative names: Potassium channel tetramerization domain-containing protein 19
All UniProt accessions (5): Q17RG1, H3BVC0, J3KRQ9, J3KSZ9, J3QKV2
UniProt curated annotations — full annotation on UniProt →
Function. Transcription regulator which is essential for male fertility and for the completion of meiotic prophase in spermatocytes. Regulates progression of the pachytene stage of meiotic prophase and promotes the transcriptional activation activity ZNF541. Required for the organization of chromosomes during metaphase I.
Subunit / interactions. Identified in a complex with ZNF541, HDAC1 and HSPA2. Identified in a complex with ZNF541 and HDAC1. Identified in a complex with HDAC1, HDAC2, DNTTIP1 and ZNF541.
Subcellular location. Nucleus.
RefSeq proteins (1): NP_001094385* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003131 | T1-type_BTB | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
Pfam: PF02214
UniProt features (8 total): domain 2, chain 1, region of interest 1, compositionally biased region 1, modified residue 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q17RG1-F1 | 66.53 | 0.31 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 270
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 30 (showing top):
chr16q22, GOBP_MALE_GAMETE_GENERATION, GOBP_ORGANELLE_FISSION, GOBP_PROTEIN_HOMOOLIGOMERIZATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MEIOTIC_CELL_CYCLE_PROCESS, GOBP_MEIOTIC_CELL_CYCLE, GOBP_CELL_CYCLE_PROCESS, GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION, GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION, ZNF2_TARGET_GENES, ZNF274_TARGET_GENES, ZNF512_TARGET_GENES, ZNF843_TARGET_GENES, GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN
GO Biological Process (5): male meiotic nuclear division (GO:0007140), spermatogenesis (GO:0007283), cell differentiation (GO:0030154), protein homooligomerization (GO:0051260), meiotic cell cycle (GO:0051321)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| male gamete generation | 2 |
| meiotic nuclear division | 2 |
| meiotic cell cycle | 1 |
| developmental process involved in reproduction | 1 |
| cellular developmental process | 1 |
| protein complex oligomerization | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| protein binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
3197 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KCTD19 | DNTTIP1 | Q9H147 | 664 |
| KCTD19 | KCTD3 | Q9Y597 | 645 |
| KCTD19 | KCTD20 | Q7Z5Y7 | 643 |
| KCTD19 | BTBD10 | Q9BSF8 | 641 |
| KCTD19 | SHKBP1 | Q8TBC3 | 615 |
| KCTD19 | KCTD18 | Q6PI47 | 603 |
| KCTD19 | PLEKHG4 | Q58EX7 | 585 |
| KCTD19 | HDAC1 | Q13547 | 558 |
| KCTD19 | MIDEAS | Q6PJG2 | 547 |
| KCTD19 | TNFAIP1 | Q13829 | 541 |
| KCTD19 | MEIKIN | A0A087WXM9 | 535 |
| KCTD19 | KCTD8 | Q6ZWB6 | 533 |
| KCTD19 | HSPA2 | P54652 | 529 |
| KCTD19 | KCTD5 | Q9NXV2 | 515 |
| KCTD19 | KCTD9 | Q7L273 | 514 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KCTD19 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KCTD19 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZSCAN22 | KCTD19 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DYRK1A | TEX13D | psi-mi:“MI:0914”(association) | 0.350 |
| KCTD19 | ECT2L | psi-mi:“MI:0914”(association) | 0.350 |
| KCTD19 | ZSCAN22 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (8): KCTD19 (Two-hybrid), ZSCAN22 (Two-hybrid), ECT2L (Affinity Capture-MS), KCTD15 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS), KCTD19 (Affinity Capture-MS)
ESM2 similar proteins: A0A5K7RLP0, A1YEX3, A7YWH3, B1WBU4, O15151, O35618, O43298, O88850, P24278, P97303, Q01954, Q0V8G8, Q15916, Q17RG1, Q562E2, Q5RC05, Q5RDQ6, Q5SXH7, Q5TC79, Q5VYS8, Q5W0Q7, Q5XIN1, Q6ZPY5, Q6ZSB9, Q6ZU67, Q7ZUW7, Q7ZYI3, Q8BLK9, Q8BSV3, Q8IW35, Q8K088, Q8N680, Q8N7W2, Q8TCN5, Q8VHI4, Q8WW38, Q90W33, Q96BR9, Q96S38, Q99ME3
Diamond homologs: A3KMV1, A4IFB4, A5PKG7, A6H6X4, A7YWH3, A9ULR9, B1WC97, B5DEL1, D5SHR0, O70479, O88759, P0C5J9, P15388, P17971, P25122, P48547, P59994, P59995, Q03607, Q03719, Q09389, Q0VD00, Q0VFV7, Q13829, Q14681, Q17RG1, Q28DC9, Q2HJ48, Q2T9W0, Q2TUM3, Q3URF8, Q4G0X4, Q50H33, Q52PG9, Q54KH0, Q562E2, Q58DF7, Q5DTY9, Q5F3E8, Q5M956
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
135 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 114 |
| Likely benign | 6 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 224816 | NM_001100915.3(KCTD19):c.215C>A (p.Thr72Asn) | Likely pathogenic |
SpliceAI
2903 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:67291461:CTT:C | acceptor_gain | 1.0000 |
| 16:67291464:C:CC | acceptor_gain | 1.0000 |
| 16:67294574:GCTT:G | donor_loss | 1.0000 |
| 16:67294578:A:AC | donor_gain | 1.0000 |
| 16:67294578:AC:A | donor_loss | 1.0000 |
| 16:67294578:ACTT:A | donor_gain | 1.0000 |
| 16:67294579:C:CT | donor_gain | 1.0000 |
| 16:67294579:CT:C | donor_gain | 1.0000 |
| 16:67294579:CTT:C | donor_gain | 1.0000 |
| 16:67294579:CTTC:C | donor_gain | 1.0000 |
| 16:67294579:CTTCT:C | donor_gain | 1.0000 |
| 16:67294581:T:TA | donor_gain | 1.0000 |
| 16:67294642:T:TA | donor_gain | 1.0000 |
| 16:67294690:ATGAC:A | acceptor_gain | 1.0000 |
| 16:67294691:TGAC:T | acceptor_gain | 1.0000 |
| 16:67294692:GAC:G | acceptor_gain | 1.0000 |
| 16:67294693:AC:A | acceptor_gain | 1.0000 |
| 16:67294693:ACC:A | acceptor_loss | 1.0000 |
| 16:67294694:CC:C | acceptor_gain | 1.0000 |
| 16:67294694:CCTG:C | acceptor_loss | 1.0000 |
| 16:67294695:C:CC | acceptor_gain | 1.0000 |
| 16:67294696:T:A | acceptor_loss | 1.0000 |
| 16:67294705:C:T | acceptor_gain | 1.0000 |
| 16:67294971:A:AC | donor_gain | 1.0000 |
| 16:67294972:C:CC | donor_gain | 1.0000 |
| 16:67297498:CTTA:C | donor_gain | 1.0000 |
| 16:67297501:A:AC | donor_gain | 1.0000 |
| 16:67297502:C:CC | donor_gain | 1.0000 |
| 16:67297502:CTGAG:C | donor_gain | 1.0000 |
| 16:67299361:A:AC | donor_gain | 1.0000 |
AlphaMissense
6053 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:67320605:A:G | L95P | 0.999 |
| 16:67320621:C:G | A90P | 0.999 |
| 16:67320812:A:T | V26D | 0.999 |
| 16:67295296:C:G | R453T | 0.998 |
| 16:67303203:A:G | W196R | 0.998 |
| 16:67303203:A:T | W196R | 0.998 |
| 16:67320680:A:G | L70P | 0.998 |
| 16:67320684:A:C | Y69D | 0.998 |
| 16:67320701:A:G | F63S | 0.998 |
| 16:67320710:C:T | G60D | 0.998 |
| 16:67320714:C:G | D59H | 0.998 |
| 16:67320817:G:C | F24L | 0.998 |
| 16:67320817:G:T | F24L | 0.998 |
| 16:67320819:A:G | F24L | 0.998 |
| 16:67320830:C:T | G20E | 0.998 |
| 16:67320831:C:A | G20W | 0.998 |
| 16:67320839:A:G | F17S | 0.998 |
| 16:67295295:T:A | R453S | 0.997 |
| 16:67295295:T:G | R453S | 0.997 |
| 16:67304567:A:G | L102P | 0.997 |
| 16:67320596:A:G | L98S | 0.997 |
| 16:67320700:A:C | F63L | 0.997 |
| 16:67320700:A:T | F63L | 0.997 |
| 16:67320702:A:G | F63L | 0.997 |
| 16:67320713:T:A | D59V | 0.997 |
| 16:67320780:A:G | S37P | 0.997 |
| 16:67320818:A:G | F24S | 0.997 |
| 16:67295052:A:G | W466R | 0.996 |
| 16:67295052:A:T | W466R | 0.996 |
| 16:67295304:G:C | N450K | 0.996 |
dbSNP variants (sampled 300 via entrez): RS1000129864 (16:67289884 C>T), RS1000217128 (16:67299927 C>T), RS1000297597 (16:67324985 G>C), RS1000314267 (16:67303931 T>C), RS1000428926 (16:67303533 C>G), RS1000482306 (16:67295276 G>A), RS1000588618 (16:67318997 T>G), RS1000625039 (16:67294753 G>A,T), RS1000694982 (16:67296415 T>G), RS1000790994 (16:67308179 T>C), RS1000879868 (16:67309964 A>G), RS1000885876 (16:67307623 A>G), RS1001168679 (16:67317628 A>G), RS1001181530 (16:67300306 G>T), RS1001281986 (16:67325775 A>G)
Disease associations
OMIM: gene MIM:619943 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004063_120 | Waist circumference adjusted for body mass index | 2.000000e-08 |
| GCST004063_121 | Waist circumference adjusted for body mass index | 5.000000e-06 |
| GCST004500_115 | Waist circumference adjusted for BMI (adjusted for smoking behaviour) | 8.000000e-11 |
| GCST004500_73 | Waist circumference adjusted for BMI (adjusted for smoking behaviour) | 7.000000e-09 |
| GCST004501_98 | Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) | 2.000000e-11 |
| GCST004501_99 | Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) | 2.000000e-09 |
| GCST004504_70 | Waist circumference adjusted for BMI in non-smokers | 5.000000e-09 |
| GCST004504_71 | Waist circumference adjusted for BMI in non-smokers | 9.000000e-07 |
| GCST008158_46 | Body mass index | 1.000000e-06 |
| GCST010002_113 | Refractive error | 2.000000e-14 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0004318 | smoking behavior |
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| entinostat | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Tretinoin | increases expression | 1 |
| Asbestos, Crocidolite | affects methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.